Webinar: Triglycerides & CVD: It's about the risk not the number!
This promotional webinar has been initiated and funded by Recordati Pharmaceuticals Ltd and is intended for UK healthcare professionals only
Webinar Details
This promotional webinar has been initiated and funded by Recordati Pharmaceuticals Ltd and is intended for UK healthcare professionals only
Triglycerides & CVD: It's about the risk not the number!
Wednesday 8th July
1pm - 2pm
Three key takeaways
- Clarify the clinical significance of triglycerides >1.7 mmol/L and their role in increasing cardiovascular disease risk.
- Define residual cardiovascular risk and explore the key contributing factors beyond standard lipid management.
- Provide practical approaches to identifying at-risk patients in general practice and implementing evidence-based changes in line with National and NICE guidelines.
Chair:
Philip Griffiths, Care Home Clinical Pharmacist, Beacon Medical Group
Speakers
Dr Mo Elnaggar
Consultant Endocrinologist, Lipidologist and Clinical Lead for Lipid services at University Hospitals of Morecambe Bay NHS Foundation Trust
Dr Mohamed Elnaggar is a Consultant Endocrinologist, Lipidologist and Clinical Lead for Lipid services at University Hospitals of Morecambe Bay NHS Foundation Trust. He is also currently the Clinical Lipid lead of South Cumbria and Lancashire. Dr Elnaggar has been involved in Diabetes and Lipidology teaching and research as a lecturer at the Alexandria Faculty of Medicine. He has developed a large experience dealing with patients suffering from dyslipidemia, diabetes and obesity over the years since he completed his training program in his native Egypt. Dr Elnaggar has been instrumental in setting up his local Lipid service and in initiating local guidelines and pathways for lipid management as well as implementing innovative methods in managing CVRM disease.
Dr Amar Ali
GP Partner at Oakenhurst Medical Practice, Blackburn
Dr Amar Ali is a GP Partner at Oakenhurst Medical Practice, Blackburn. He is also a GP with specialist interest in diabetes and undertakes clinical research in his role. He has had a keen interest in education and upskilling collegues to translate evidence into practice and improve the standard of care of treatment for patients.
UK-VAZK-0213 June 2026
